Catalog Number UNK EMBOSHIELD NAV6 |
Device Problems
Difficult to Insert (1316); Activation Failure (3270)
|
Patient Problems
Stroke/CVA (1770); Myocardial Infarction (1969); Renal Failure (2041); Transient Ischemic Attack (2109); Perforation of Vessels (2135); Obstruction/Occlusion (2422); Respiratory Failure (2484); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
|
Event Date 01/01/2014 |
Event Type
Injury
|
Manufacturer Narrative
|
Age - average.Date of event ¿ estimated.The unique device identifier (udi) is unknown because the part number and lot number were not provided.Date of implant ¿ estimated.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effects of stroke, transient ischemic attack (tia), myocardial infarction (mi), unspecified tissue injury, respiratory failure, renal failure, thrombosis/thrombus, obstruction/occlusion, embolism/embolus, vascular dissection, and perforation of vessels are listed in the emboshield nav6 instruction for use (ifu), as known possible adverse events potentially associated with carotid stents and embolic protection devices based on the information reported through the pmcf report, a definitive cause for the reported difficulty to insert and activation failure could not be determined.Additionally, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The patient deaths and the other adverse events reported in the pmcf are filed under separate medwatch report numbers.Attachment: title ¿post market clinical follow-up evaluation report abbott carotid stent and embolic protection systems¿na.
|
|
Event Description
|
It was reported through the post market clinical follow-up (pmcf) report, that the emboshield nav6 embolic protection device may be related to the adverse patient effects of death, myocardial infarction, access site complications, pulmonary complications, renal complications, transient ischemic attack, stroke, thrombosis, occlusion, embolization, dissection, perforation, intervention, medication administration, amputation / surgery and re-hospitalization and device issues of unable to insert and unsuccessful placement.Details are listed in the attached article, titled post market clinical follow-up evaluation report abbott carotid stent and embolic protection systems.
|
|
Search Alerts/Recalls
|
|